Literature DB >> 23397619

The blood-retina barrier: tight junctions and barrier modulation.

Matthew Campbell1, Peter Humphries.   

Abstract

The blood-retina barrier (BRB) is composed of both an inner and an outer barrier. The outer BRB refers to the barrier formed at the retinal pigment epithelial (RPE) cell layer and functions, in part, to regulate the movement of solutes and nutrients from the choroid to the sub-retinal space. In contrast, the inner BRB, similar to the blood brain barrier (BBB) is located in the inner retinal microvasculature and comprises the microvascular endothelium which line these vessels. The tight junctions located between these cells mediate highly selective diffusion of molecules from the blood to the retina and the barrier is essential in maintaining retinal homeostasis. In this chapter, we summarize the key differences between the iBRB and oBRB and outline the molecular constituents of the tight junctions associated with the iBRB. We also describe a process for modulation of the iBRB to enhance systemic delivery of therapeutics to the retina, a technology which may pave the way for safer and more effective therapies for retinal diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23397619

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  72 in total

Review 1.  Effective Delivery of Male Contraceptives Behind the Blood-Testis Barrier (BTB) - Lesson from Adjudin.

Authors:  Haiqi Chen; Dolores D Mruk; Weiliang Xia; Michele Bonanomi; Bruno Silvestrini; Chuen-Yan Cheng
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

Review 2.  Probing Metabolism in the Intact Retina Using Stable Isotope Tracers.

Authors:  Jianhai Du; Jonathan D Linton; James B Hurley
Journal:  Methods Enzymol       Date:  2015-06-14       Impact factor: 1.600

3.  Erianin alleviates diabetic retinopathy by reducing retinal inflammation initiated by microglial cells via inhibiting hyperglycemia-mediated ERK1/2-NF-κB signaling pathway.

Authors:  Tianyu Zhang; Hao Ouyang; Xiyu Mei; Bin Lu; Zengyang Yu; Kaixian Chen; Zhengtao Wang; Lili Ji
Journal:  FASEB J       Date:  2019-07-31       Impact factor: 5.191

Review 4.  Advances in ocular drug delivery systems.

Authors:  Jennifer J Kang-Mieler; Kayla M Rudeen; Wenqiang Liu; William F Mieler
Journal:  Eye (Lond)       Date:  2020-02-18       Impact factor: 3.775

5.  Blood-retina barrier failure and vision loss in neuron-specific degeneration.

Authors:  Elena Ivanova; Nazia M Alam; Glen T Prusky; Botir T Sagdullaev
Journal:  JCI Insight       Date:  2019-03-19

6.  A ligand motif enables differential vascular targeting of endothelial junctions between brain and retina.

Authors:  Fenny H F Tang; Fernanda I Staquicini; André A R Teixeira; Jussara S Michaloski; Gislene M Namiyama; Noemi N Taniwaki; João C Setubal; Aline M da Silva; Richard L Sidman; Renata Pasqualini; Wadih Arap; Ricardo J Giordano
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-22       Impact factor: 11.205

Review 7.  Ocular cytochrome P450s and transporters: roles in disease and endobiotic and xenobiotic disposition.

Authors:  Mariko Nakano; Catherine M Lockhart; Edward J Kelly; Allan E Rettie
Journal:  Drug Metab Rev       Date:  2014-05-26       Impact factor: 4.518

8.  Thioredoxin Interacting Protein (TXNIP) and Pathogenesis of Diabetic Retinopathy.

Authors:  Lalit P Singh
Journal:  J Clin Exp Ophthalmol       Date:  2013-08-05

Review 9.  Bioactive lipids and pathological retinal angiogenesis.

Authors:  Khaled Elmasry; Ahmed S Ibrahim; Samer Abdulmoneim; Mohamed Al-Shabrawey
Journal:  Br J Pharmacol       Date:  2018-11-19       Impact factor: 8.739

10.  Activation of Rap1 inhibits NADPH oxidase-dependent ROS generation in retinal pigment epithelium and reduces choroidal neovascularization.

Authors:  Haibo Wang; Yanchao Jiang; Dallas Shi; Lawrence A Quilliam; Magdalena Chrzanowska-Wodnicka; Erika S Wittchen; Dean Y Li; M Elizabeth Hartnett
Journal:  FASEB J       Date:  2013-09-16       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.